NCT02376595View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic of Rocuronium

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

January 31, 2015

Conditions
Neuromuscular Blockade
Interventions
DRUG

Rocuronium Bromide

Rocuronium 0,3 mg/kg in less than five seconds, followed by a saline bolus.

All Listed Sponsors
lead

Pontificia Universidad Catolica de Chile

OTHER

NCT02376595 - Pharmacokinetic and Pharmacodynamic of Rocuronium | Biotech Hunter | Biotech Hunter